drugset / Trial / NCT00722917
Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of multiple doses of TAK-379, once daily (QD), in subjects with type 2 diabetes mellitus.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |
| Subject | TAK-379 | Unknown | 25 mg | Oral |
| Subject | TAK-379 | Unknown | 100 mg | Oral |
| Subject | TAK-379 | Unknown | 200 mg | Oral |